95 related articles for article (PubMed ID: 6789431)
1. [Induction and termination of ventricular tachycardia by programmed electrical stimulation of heart--a case in which the effect of disopyramide phosphate was confirmed by the stimulation study (author's transl)].
Komatsu C; Ishinaga T; Motoyama M; Marutani K; Teruya H; Nakayama M; Kuno A; Sato Y; Yoshimura S
Kokyu To Junkan; 1981 Feb; 29(2):209-15. PubMed ID: 6789431
[No Abstract] [Full Text] [Related]
2. Recurrent ventricular tachycardia in man: evaluation of disopyramide therapy by intracardiac electrical stimulation.
Benditt DG; Pritchett EL; Wallace AG; Gallagher JJ
Eur J Cardiol; 1979 Apr; 9(4):255-76. PubMed ID: 428417
[No Abstract] [Full Text] [Related]
3. Intravenous disopyramide phosphate and ventricular overdrive pacing in the termination of paroxysmal ventricular tachycardia.
Camm J; Ward D; Washington HG; Spurrell RA
Pacing Clin Electrophysiol; 1979 Jul; 2(4):395-402. PubMed ID: 95308
[TBL] [Abstract][Full Text] [Related]
4. [Clinical studies of the antiarrhythmic efficacy of disopyramide phosphate (Norpace) (author's transl)].
Smith WS
Herz; 1978 Dec; 63(36):399-406. PubMed ID: 95482
[TBL] [Abstract][Full Text] [Related]
5. Corrected data on disopyramide phosphate (Norpace).
Agre K
Geriatrics; 1981 Jul; 36(7):139. PubMed ID: 6786958
[No Abstract] [Full Text] [Related]
6. [Antiarrhythmic actions of disopyramide phosphate in patients with paroxysmal supraventricular tachycardia (author's transl)].
Satoh M; Sada T; Kuan-Min S; Kira Y; Sekine I; Okabe F; Ueda A; Ito T; Matsumoto S
Kokyu To Junkan; 1981 May; 29(5):537-44. PubMed ID: 7313358
[No Abstract] [Full Text] [Related]
7. Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation.
Manz M; Steinbeck G; Nitsch J; Lüderitz B
Br Heart J; 1983 Mar; 49(3):222-8. PubMed ID: 6830659
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral disopyramide phosphate on induction and sustenance of atrioventricular reentrant tachycardia incorporating retrograde accessory pathway conduction.
Kou HC; Hung JS; Lee YS; Wu D
Circulation; 1982 Aug; 66(2):454-62. PubMed ID: 6807567
[TBL] [Abstract][Full Text] [Related]
9. [Action of injectable disopyramide phosphate in the emergency treatment of ventricular tachycardia].
Valère PE; Guerot C; Castillo Fenoy A; Branvin E; Urbanczyk A; Tricot R
Coeur Med Interne; 1977; 16(2):285-92. PubMed ID: 891126
[No Abstract] [Full Text] [Related]
10. [Therapy of ventricular tachyarrhythmia with disopyramid phosphate].
Steinbrunn W; Mattmann H; Enrico JF; Engel U
Schweiz Med Wochenschr; 1980 Jun; 110(24):953-7. PubMed ID: 7414314
[TBL] [Abstract][Full Text] [Related]
11. [Effects of intravenous disopyramide on induction and termination of paroxysmal supraventricular tachycardia via an accessory pathway].
Komatsu C; Ishinaga T; Tateishi O; Tokuhisa Y; Hara M; Sanada T; Kanae K; Satoh Y; Yoshimura S
Kokyu To Junkan; 1984 Apr; 32(4):409-14. PubMed ID: 6463419
[No Abstract] [Full Text] [Related]
12. [Initiation and termination of ventricular tachycardia by electrical stimulation (author's transl)].
Breithardt G; Seipel L; Abendroth RR; Haerten K; Loogen F
Z Kardiol; 1979 Sep; 68(8):575-82. PubMed ID: 543206
[No Abstract] [Full Text] [Related]
13. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
Meltzer RS; Robert EW; McMorrow M; Martin RP
Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132
[TBL] [Abstract][Full Text] [Related]
14. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
Romero-Ayala LC; Soní J
Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
[TBL] [Abstract][Full Text] [Related]
15. Induction of ventricular tachycardia during programmed electrical stimulation: analysis of pacing methods.
Prystowsky EN; Miles WM; Evans JJ; Hubbard JE; Skale BT; Windle JR; Heger JJ; Zipes DP
Circulation; 1986 Feb; 73(2 Pt 2):II32-8. PubMed ID: 3943174
[No Abstract] [Full Text] [Related]
16. Efficacy of disopyramide phosphate in the treatment of refractory ventricular arrhythmias.
Meyers DG; Mohiuddin SM
Nebr Med J; 1980 May; 65(5):123-5. PubMed ID: 7383223
[No Abstract] [Full Text] [Related]
17. [Disopyramide in the prevention of arrhythmia following myocardial infarction and resistant arrhythmia].
Dallocchio M; Daubeze J; Clementy J; Poisot D; Bricaud H; Broustet P
Therapie; 1974; 29(1):119-29. PubMed ID: 4848509
[No Abstract] [Full Text] [Related]
18. Increased AAI mode pacing threshold after termination of atrial fibrillation by acute administration of disopyramide phosphate.
Anzawa R; Ishikawa S; Tanaka Y; Okazaki F; Mochizuki S
Europace; 2006 May; 8(5):345-8. PubMed ID: 16635993
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of Rhytmodan in heart rhythm disorders].
Dzieglielewski T; Wachowiak A
Pol Tyg Lek; 1973 Dec; 28(52):2065-7. PubMed ID: 4769022
[No Abstract] [Full Text] [Related]
20. [Clinical efficacy of disopyramide in the treatment of cardiac arrhythmias (author's transl)].
Li JC
Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Dec; 8(4):260-3. PubMed ID: 7307962
[No Abstract] [Full Text] [Related]
[Next] [New Search]
